This study evaluates adherence to guidelines by heart failure clinicians (HFCs) vs general cardiologists (GCs) for use of implantable cardioverter-defibrillators (ICDs), biventricular pacing devices (cardiac resynchronization therapy; CRT), and use of medications for heart failure (HF). The authors reviewed 563 patients with HF and an ejection fraction ≤35% for adherence to the 2005 American College of Cardiology/American Heart Association HF guidelines for the use of ICDs, CRT, and medications. There were 324 HFC and 239 GC patients. CRT guidelines were appropriately followed in 86% of HFC and 81% of GC patients (P=NS). For primary arrhythmia prevention, an ICD was implanted in 107 (42%) HFC and 50 (25%) GC patients ( P<004). Guidelines were appropriately followed in 77% of HFC and 74% of GC patients ( P=NS). For medications, dose intensity of diuretics, β-blockers, and angiotensin-converting enzyme inhibitors was significantly greater in HFC than GC patients. Guideline-recommended β-blockers were more frequently utilized by HFCs (97%) than GCs (82%). In conclusion, HFCs and GCs appropriately follow guidelines in the majority of cases, but HFCs use appropriate medications at higher dose intensity. © 2009 Wiley Periodicals, Inc.
CITATION STYLE
Asghar, H., & Rahko, P. S. (2010). Quality of heart failure management: A comparison of care between a comprehensive heart failure program and a general cardiology practice. Congestive Heart Failure, 16(2), 65–70. https://doi.org/10.1111/j.1751-7133.2009.00136.x
Mendeley helps you to discover research relevant for your work.